Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic

  • Evotec SE and biotech venture capital firm Claris Ventures (“Claris”) today announced an acceleration framework to streamline programmes from Claris’s portfolio companies into the clinic through Evotec’s fully integrated platform. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-claris-ventures-streamline-access-to-accelerate-programmes-from-clariss-portfolio-companies-into-the-clinic-6374

    Du magst vielleicht auch